CIBMTR provides:
Invaluable expertise. Innovative Insights. Improved Success Rates.
CIBMTR offers more than 50 years of data and research experience improving survival, treatment, and quality of life for patients receiving hematopoietic cell transplantation (HCT); other cellular therapies, such as chimeric antigen receptor (CAR)-T cells; and gene therapies.
We can help. Tell us about your project.